Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CKDXF

Ceryvyn Therapeutics Limited

USD

Set alert

Price alert · CKDXF

All alert types
0.01 USD 0.00 0.00%
As of Oct 29, 2026
0.29 Day range 0.29
0.01 52-week range 0.44
YTD
-97.57%
1 year
-97.57%
Open
0.29
Prev close
0.0107
Mkt cap
14.64M
Vol
130
Avg vol
85
EPS
0.17
P/E
0.06
More statistics
Low
0.29
High
0.29

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CKDXF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-25.60 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A+4 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 4
  • P/B 5

Valuation

P/E 0.1×
FY 2017: -20.7×FY 2018: -7.8×FY 2019: -6.4×FY 2020: -37.4×FY 2021: -6.1×FY 2022: -3.2×FY 2023: -0.9×FY 2024: -0.8×FY 2025: -3.4×FY 2026: 0.1×
FY 2017 5y median -0.9× FY 2026
P/S 20230×
FY 2017: 1707×FY 2018: 907×FY 2019: 1188×FY 2020: 4138×FY 2021: 4028×FY 2022: 3251×FY 2023: 1826×FY 2024: 1485×FY 2025: 21229×FY 2026: 20230×
FY 2017 5y median 3251× FY 2026
P/B 0.7×
FY 2017: 2.3×FY 2018: 3.4×FY 2019: 4.3×FY 2020: 9.3×FY 2021: 2.1×FY 2022: 5.8×FY 2023: -22.4×FY 2024: -2.4×FY 2025: -2.7×FY 2026: 0.7×
FY 2017 5y median -2.4× FY 2026
P/FCF -1.6×
FY 2017: -21.1×FY 2018: -6.6×FY 2019: -5.5×FY 2020: -73.2×FY 2021: -6.1×FY 2022: -4.1×FY 2023: -1.1×FY 2024: -1.1×FY 2025: -3.4×FY 2026: -1.6×
FY 2017 5y median -1.6× FY 2026
EV/EBITDA 0.9×
FY 2017: -7.7×FY 2018: -3.3×FY 2019: -3.1×FY 2020: -22.1×FY 2021: -4.3×FY 2022: -3.5×FY 2023: -1.1×FY 2024: -0.8×FY 2025: -6.0×FY 2026: 0.9×
FY 2017 5y median -1.1× FY 2026
EV/Sales -10893×
FY 2017: 1013×FY 2018: 683×FY 2019: 997×FY 2020: 3715×FY 2021: 2318×FY 2022: 2732×FY 2023: 1380×FY 2024: 1237×FY 2025: 29084×FY 2026: -10893×
FY 2017 5y median 1380× FY 2026
FCF Yield -64.0%
FY 2017: -4.7%FY 2018: -15.2%FY 2019: -18.1%FY 2020: -1.4%FY 2021: -16.5%FY 2022: -24.2%FY 2023: -90.9%FY 2024: -87.0%FY 2025: -29.4%FY 2026: -64.0%
FY 2017 5y median -64.0% FY 2026

Profitability

Gross Margin 100.0%
FY 2017: -35.6%FY 2018: -19.8%FY 2019: -143.5%FY 2020: -254.5%FY 2021: -391.7%FY 2022: -85.9%FY 2023: -82.7%FY 2024: 17.7%FY 2025: -264.0%FY 2026: 100.0%
FY 2017 5y median -82.7% FY 2026
Operating Margin -1194700.0%
FY 2017: -13219.2%FY 2018: -21985.0%FY 2019: -32595.3%FY 2020: -16795.8%FY 2021: -43098.0%FY 2022: -77201.3%FY 2023: -138912.0%FY 2024: -153885.4%FY 2025: -613622.8%FY 2026: -1194700.0%
FY 2017 5y median -153885.4% FY 2026
Net Margin 33044499.9%
FY 2017: -8272.6%FY 2018: -11650.4%FY 2019: -18587.2%FY 2020: -11255.2%FY 2021: -66087.6%FY 2022: -102353.7%FY 2023: -196185.8%FY 2024: -176665.7%FY 2025: -641313.4%FY 2026: 33044499.9%
FY 2017 5y median -176665.7% FY 2026
ROE 1076.3%
FY 2017: -11.4%FY 2018: -44.3%FY 2019: -67.2%FY 2020: -25.3%FY 2021: -33.7%FY 2022: -183.4%FY 2023: 2409.6%FY 2024: 290.5%FY 2025: 81.0%FY 2026: 1076.3%
FY 2017 5y median 290.5% FY 2026
ROIC -38.9%
FY 2017: -12.0%FY 2018: -48.8%FY 2019: -69.3%FY 2020: -24.5%FY 2021: -26.4%FY 2022: -212.2%FY 2023: -111.2%FY 2024: -147.4%FY 2025: -319.4%FY 2026: -38.9%
FY 2017 5y median -147.4% FY 2026
ROA 998.2%
FY 2017: -11.0%FY 2018: -36.7%FY 2019: -55.5%FY 2020: -22.8%FY 2021: -33.0%FY 2022: -146.6%FY 2023: -143.0%FY 2024: -116.7%FY 2025: -286.6%FY 2026: 998.2%
FY 2017 5y median -143.0% FY 2026

Growth (YoY)

Revenue -97.4%
FY 2017: -77.8%FY 2018: 93.8%FY 2019: -22.5%FY 2020: 29.7%FY 2021: -37.0%FY 2022: 35.9%FY 2023: -13.6%FY 2024: 15.4%FY 2025: -79.6%FY 2026: -97.4%
FY 2017 FY 2026
Operating Income 94.9%
FY 2017: -22.4%FY 2018: -222.3%FY 2019: -15.0%FY 2020: 33.2%FY 2021: -61.8%FY 2022: -143.5%FY 2023: -55.4%FY 2024: -27.9%FY 2025: 18.8%FY 2026: 94.9%
FY 2017 FY 2026
EPS (diluted) 223.1%
FY 2017: 11.4%FY 2018: -118.6%FY 2019: -23.4%FY 2020: 31.2%FY 2021: -191.3%FY 2022: -88.9%FY 2023: -32.4%FY 2024: 22.2%FY 2025: 62.9%FY 2026: 223.1%
FY 2017 FY 2026
Free Cash Flow 94.6%
FY 2017: -63.8%FY 2018: -230.2%FY 2019: -21.2%FY 2020: 65.9%FY 2021: -640.5%FY 2022: -61.1%FY 2023: -82.3%FY 2024: 10.2%FY 2025: 1.5%FY 2026: 94.6%
FY 2017 FY 2026

Financial Health

Current Ratio 13.8×
FY 2017: 27.6×FY 2018: 5.7×FY 2019: 5.7×FY 2020: 10.3×FY 2021: 44.5×FY 2022: 3.4×FY 2023: 7.9×FY 2024: 2.9×FY 2025: 0.2×FY 2026: 13.8×
FY 2017 5y median 3.4× FY 2026
Quick Ratio 13.8×
FY 2017: 27.6×FY 2018: 5.7×FY 2019: 5.7×FY 2020: 10.3×FY 2021: 44.5×FY 2022: 3.4×FY 2023: 7.9×FY 2024: 2.9×FY 2025: 0.2×FY 2026: 13.8×
FY 2017 5y median 3.4× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -9.8×FY 2024: -1.9×FY 2025: -1.2×FY 2026: 0.0×
FY 2017 5y median -1.2× FY 2026
Net Debt / EBITDA 2.5×
FY 2017: 5.3×FY 2018: 1.1×FY 2019: 0.6×FY 2020: 2.5×FY 2021: 3.1×FY 2022: 0.7×FY 2023: 0.4×FY 2024: 0.2×FY 2025: -1.6×FY 2026: 2.5×
FY 2017 5y median 0.4× FY 2026
Interest Coverage -1.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -11.1×FY 2024: -6.3×FY 2025: -3.4×FY 2026: -1.0×
FY 2017 5y median -3.4× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30